Back to Search Results

Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression.

Department of Thoracic/Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

Journal of the National Cancer Institute. 2000;(1):69-73

Full text from:

Subscription
- Ovid Technologies, Inc.
- Silverchair Information Systems

Methodological quality

Publication Type : Clinical Trial ; Clinical Trial

Metadata

MeSH terms : Anticarcinogenic Agents ; Antineoplastic Combined Chemotherapy Protocols ; Gene Expression Regulation, Neoplastic ; Mutation